Chronic Myeloid Leukemia Clinical Trials

A listing of Chronic Myeloid Leukemia medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

California

Los Angeles California 90033

A clinical trial seeking patients for a research study for the treatment of Previously Treated PH + CML

Los Angeles California 90033

A clinical trial seeking patients for a research study for the treatment of Previously Treated PH + CML

Los Angeles California 90033

A clinical trial seeking patients for a research study for the treatment of Previously Treated PH + CML

Los Angeles California 90033

A clinical trial seeking patients for a research study for the treatment of Previously Treated PH + CML

Colorado

Denver Colorado 80218

A Phase 1 clinical study for patients with Advanced, Refractory Hematologic Malignancy

Florida

Miami Florida 33136

A clinical trial seeking patients for a research study for the treatment of Previously Treated PH + CML

Tampa Florida 33612

A Phase 1 clinical study for patients with Chronic Myeloid Leukemia (CML)

Georgia

Atlanta Georgia 30322

A clinical research study of Dasatinib and Nivolumab for the treatment of Chronic Myeloid Leukemia

Atlanta Georgia

Patients are needed to participate in a clinical research study of Omacetaxine mepesuccinate to evaluate Chronic Myeloid Leukemia

Indiana

Indianapolis Indiana 46237

A clinical trial seeking patients for a research study for the treatment of Previously Treated PH + CML

Indianapolis Indiana 46237

A clinical trial seeking patients for a research study for the treatment of Previously Treated PH + CML

Indianapolis Indiana 46202

A Phase 1 clinical study for patients with Advanced, Refractory Hematologic Malignancy

Indianapolis Indiana

Patients are needed to participate in a clinical research study of Omacetaxine mepesuccinate to evaluate Chronic Myeloid Leukemia

Maryland

Baltimore Maryland 21287

A clinical trial seeking patients for a research study for the treatment of Previously Treated PH + CML

Massachusetts

Boston Massachusetts 02215

A Phase 1 clinical study for patients with Chronic Myelogenous Leukemia

Michigan

Ann Arbor Michigan 48109

A clinical trial seeking patients for a research study for the treatment of Previously Treated PH + CML

Missouri

Creve Coeur Missouri 63141-6337

A clinical trial seeking patients for a research study for the treatment of Previously Treated PH + CML

St. Louis Missouri 63110

A clinical trial seeking patients for a research study for the treatment of Previously Treated PH + CML

St. Louis Missouri 63110

A clinical trial seeking patients for a research study for the treatment of Previously Treated PH + CML

St. Louis Missouri 63110

A clinical trial seeking patients for a research study for the treatment of Previously Treated PH + CML

St. Louis Missouri 63129

A clinical trial seeking patients for a research study for the treatment of Previously Treated PH + CML

New York

New York New York 10021

A clinical trial seeking patients for a research study for the treatment of Previously Treated PH + CML

New York New York 10065

A clinical trial seeking patients for a research study for the treatment of Previously Treated PH + CML

New York New York 10065

A clinical trial seeking patients for a research study for the treatment of Previously Treated PH + CML

Texas

UPDATED

Houston Texas 77030

A clinical trial to evaluate treatments using Eltrombopag for patients with Leukemia

Dallas Texas 75390

A clinical research study of Dasatinib and Nivolumab for the treatment of Chronic Myeloid Leukemia

Houston Texas 77030

A clinical research study of Dasatinib and Decitabine for the treatment of Leukemia

Houston Texas 77030

A clinical research study of Dasatinib and Nivolumab for the treatment of Chronic Myeloid Leukemia

Houston Texas

Patients are needed to participate in a clinical research study of Omacetaxine mepesuccinate to evaluate Chronic Myeloid Leukemia

View More ▼

Houston Texas 77030

Patients are needed to participate in a clinical research study of Ruxolitinib and TKI to evaluate Leukemia

San Antonio Texas 78229

A Phase 1 clinical study for patients with Advanced, Refractory Hematologic Malignancy

San Antonio Texas 78217

A Phase 1 clinical study for patients with Advanced, Refractory Hematologic Malignancy

Virginia

Fairfax Virginia 22031

A Phase 1 clinical study for patients with Advanced, Refractory Hematologic Malignancy

Norfolk Virginia 23502

A Phase 1 clinical study for patients with Advanced, Refractory Hematologic Malignancy

Washington

Seattle Washington 98109

A clinical trial seeking patients for a research study for the treatment of Previously Treated PH + CML

Vancouver Washington 98684

A Phase 1 clinical study for patients with Advanced, Refractory Hematologic Malignancy

Wisconsin

Milwaukee Wisconsin 53226

A clinical research study of Dasatinib and Nivolumab for the treatment of Chronic Myeloid Leukemia

Australia

UPDATED

Liverpool New South Wales 2170

A clinical trial to evaluate treatments using Nilotinib for patients with Philidelphia Positive Chronic Myeloid Leukaemia

UPDATED

South Brisbane Queensland 4101

A clinical trial to evaluate treatments using Nilotinib for patients with Philidelphia Positive Chronic Myeloid Leukaemia

UPDATED

St. Leonards New South Wales 2065

A clinical trial to evaluate treatments using Nilotinib for patients with Philidelphia Positive Chronic Myeloid Leukaemia

Canada

UPDATED

Calgary Alberta

A clinical trial to evaluate treatments using Dasatinib for patients with Chronic Myeloid Leukemia (CML)

UPDATED

Charlesbourg Quebec

A clinical trial to evaluate treatments using Dasatinib for patients with Chronic Myeloid Leukemia (CML)

UPDATED

Halifax Nova Scotia

A clinical trial to evaluate treatments using Dasatinib for patients with Chronic Myeloid Leukemia (CML)

UPDATED

Hamilton Ontario

A clinical trial to evaluate treatments using Dasatinib for patients with Chronic Myeloid Leukemia (CML)

UPDATED

London Ontario

A clinical trial to evaluate treatments using Dasatinib for patients with Chronic Myeloid Leukemia (CML)

View More ▼

UPDATED

Montreal Quebec

A clinical trial to evaluate treatments using Dasatinib for patients with Chronic Myeloid Leukemia (CML)

UPDATED

Ottawa Ontario

A clinical trial to evaluate treatments using Dasatinib for patients with Chronic Myeloid Leukemia (CML)

UPDATED

Toronto Ontario M5G 2M9

A clinical trial to evaluate treatments using Dasatinib for patients with Chronic Myeloid Leukemia (CML)

UPDATED

Vancouver British Columbia V5Z1M9

A clinical trial to evaluate treatments using Dasatinib for patients with Chronic Myeloid Leukemia (CML)

Germany

UPDATED

Berlin 13353

A Phase 1/Phase 2 clinical study for patients with Chronic Myeloid Leukemia (CML)